Steroid Eluting Esophageal-Targeted Drug Delivery Devices for Treatment of Eosinophilic Esophagitis
Open Access
- 13 February 2021
- Vol. 13 (4), 557
- https://doi.org/10.3390/polym13040557
Abstract
Eosinophilic esophagitis (EoE) is a chronic atopic disease that has become increasingly prevalent over the past 20 years. A first-line pharmacologic option is topical/swallowed corticosteroids, but these are adapted from asthma preparations such as fluticasone from an inhaler and yield suboptimal response rates. There are no FDA-approved medications for the treatment of EoE, and esophageal-specific drug formulations are lacking. We report the development of two novel esophageal-specific drug delivery platforms. The first is a fluticasone-eluting string that could be swallowed similar to the string test “entero-test” and used for overnight treatment, allowing for a rapid release along the entire length of esophagus. In vitro drug release studies showed a target release of 1 mg/day of fluticasone. In vivo pharmacokinetic studies were carried out after deploying the string in a porcine model, and our results showed a high local level of fluticasone in esophageal tissue persisting over 1 and 3 days, and a minimal systemic absorption in plasma. The second device is a fluticasone-eluting 3D printed ring for local and sustained release of fluticasone in the esophagus. We designed and fabricated biocompatible fluticasone-loaded rings using a top-down, Digital Light Processing (DLP) Gizmo 3D printer. We explored various strategies of drug loading into 3D printed rings, involving incorporation of drug during the print process (pre-loading) or after printing (post-loading). In vitro drug release studies of fluticasone-loaded rings (pre and post-loaded) showed that fluticasone elutes at a constant rate over a period of one month. Ex vivo pharmacokinetic studies in the porcine model also showed high tissue levels of fluticasone and both rings and strings were successfully deployed into the porcine esophagus in vivo. Given these preliminary proof-of-concept data, these devices now merit study in animal models of disease and ultimately subsequent translation to testing in humans.Keywords
Funding Information
- University of North Carolina at Chapel Hill (UNC CTSA grant (UL1TR001111))
- School of Medicine, University of North Carolina at Chapel Hill (NC TraCS/NC State Collaborative Translational Research Pilot Grant Award (UNCSUR11602))
This publication has 72 references indexed in Scilit:
- Novel Device to Sample the Esophageal Microbiome—The Esophageal String TestPLOS ONE, 2012
- The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitisGut, 2012
- Fabrication of 3D biocompatible/biodegradable micro-scaffolds using dynamic mask projection microstereolithographyJournal of the American Academy of Dermatology, 2009
- Fumaric Acid Monoethyl Ester-Functionalized Poly(d,l-lactide)/N-vinyl-2-pyrrolidone Resins for the Preparation of Tissue Engineering Scaffolds by StereolithographyBiomacromolecules, 2008
- Highly Efficient, Living Coordinative Chain-Transfer Polymerization of Propene with ZnEt2: Practical Production of Ultrahigh to Very Low Molecular Weight Amorphous Atactic Polypropenes of Extremely Narrow PolydispersityJournal of the American Chemical Society, 2007
- Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and TreatmentGastroenterology, 2007
- Rapid manufacturing of PA/HDPE blend specimens by selective laser sintering: Microstructural characterizationPolymer Testing, 2007
- Erratum: Porous scaffold design for tissue engineeringNature Materials, 2006
- Investigation of the processing dependence of SL solidification residual stressesRapid Prototyping Journal, 2002
- FLUID COATING ON A FIBERAnnual Review of Fluid Mechanics, 1999